Pharma Media Buying: Publicis’ 2026 Strategy

Winning a major pharmaceutical account like Gilead Sciences isn’t about luck. It’s about having a razor-sharp agency strategy that fuses high-level media buying with granular market share analysis. Publicis, for example, builds a multi-layered plan that’s all about data-driven buys and programmatic accuracy. The agencies that consistently win and keep these accounts are the ones who have mastered a specific, repeatable process.

Setting Up Your Programmatic Media Buying Campaign for Pharmaceutical Accounts

For a pharma giant like Gilead Sciences, programmatic media buying is the only way to reach super-specific audiences while staying compliant. The process starts with a careful setup in a Demand-Side Platform (DSP). I usually recommend platforms known for their deep healthcare data integrations and targeting options, like The Trade Desk or the proprietary tools from MediaCom that often build on Xandr’s tech. The whole point is precision.

Step 1: Define Audience Segments and Data Integration

The first and most important step is defining your target audience with almost painful specificity. For a drug, this means identifying healthcare professionals (HCPs) by their specialty, where they practice, their prescribing habits, and even how they consume digital media. This has to be data-driven.

1. Access Your DSP’s Audience Manager: In The Trade Desk, you’ll go to “Audiences” on the left menu, then “Audience Segments,” and finally “Create New Segment.”
2. Integrate Third-Party Healthcare Data: This is where you get your power. Inside the “Create New Segment” wizard, find the “Data Providers” section and link up with an established healthcare data provider. You’ll want to integrate data from IQVIA or Symphony Health, which offer anonymized, aggregated data on what doctors are prescribing, medical claims, and even who attended which conference. These data sets are typically listed under “Healthcare Professional Data” or “Pharmaceutical Targeting.” From there, you can select specific data relevant to your drug, like “Oncologists specializing in lung cancer” or “Gastroenterologists with high prescription volume for biologics.”
3. Layer First-Party Data (if available): If the client has their own CRM data on HCPs (maybe from sales reps or medical education sign-ups), you can upload those anonymized lists under the “First-Party Data” option. Matching these lists against the third-party segments lets you build a completely custom audience. Keep an eye on the “Match Rate” indicator. Anything over 60% is pretty good for strong targeting.
4. Configure Geo-targeting Parameters: While still creating the audience segment, you need to define your geographic boundaries. For a new drug launch, you might target states or regions with high concentrations of patients for a specific disease. More importantly, you should be geo-fencing major medical centers or conference venues during key industry events. In the “Location” section, you can plug in specific ZIP codes, DMAs (Designated Market Areas), or even draw custom shapes on the map. For example, targeting the area around the Emory University Hospital Midtown campus in Atlanta during a cardiology conference would be a smart move for a cardiovascular drug.

Pro Tip: Always, always review the data provider’s terms of service for HIPAA compliance. Anonymization is non-negotiable. I see too many agencies make the mistake of using overly broad audience definitions, which just burns through media spend. The goal here is a tightly defined audience segment ready for activation, which drastically cuts down on wasted impressions.

Developing Creative Strategy and A/B Testing Protocols

Your targeting can be perfect, but if the creative sucks, the campaign will fail. For pharma, creative has to walk a fine line between regulatory rules, scientific fact, and a message that actually persuades someone. In the 2026 digital ad world, this means a heavy reliance on dynamic creative optimization (DCO) and constant A/B testing to get the most out of every impression.

Step 2: Designing Compliant and Engaging Ad Units

Pharma creative gets put under a microscope. Every claim, every image, and every word has to be backed up and signed off by the client’s medical, legal, and regulatory (MLR) teams. This can be a huge bottleneck. Big agencies like Publicis get around this by using dedicated MLR review platforms that plug right into their creative workflow.

1. Use DCO Platforms: In your DSP (or a separate creative management platform), head to the “Creatives” section and select “Dynamic Creative Optimization.” Tools like Adform or Adobe Ad Cloud have solid DCO functions. This is where you upload your approved creative building blocks: images, blocks of text, and calls-to-action (CTAs).
2. Set Up Dynamic Elements: Now you define the rules for the dynamic content. You could swap out headlines based on an HCP’s specialty (e.g., “New Treatment for Type 2 Diabetes” for an endocrinologist vs. “Managing Glycemic Control” for a GP). Imagery or patient testimonials can also be dynamically adjusted based on geography or a user’s past interactions. The key is that every single possible variation has to be pre-approved by MLR.
3. Develop Multiple Creative Variants for A/B Testing: For every ad unit you have (a banner, a video pre-roll, etc.), you need to make at least three different versions to test specific ideas.
   • Headline Variation: “Breakthrough in Oncology” vs. “Targeting Specific Cancer Pathways.”
   • Visual Variation: Patient-focused imagery vs. scientific diagrams.
   • Call-to-Action Variation: “Learn More” vs. “Download Clinical Data” vs. “Speak to a Rep.”

   Upload each of these variants to the DSP’s creative library and give each one a unique name so you can track it.

4. Implement A/B Testing in Your Campaign: As you build out your campaign in the DSP (usually under “Campaigns” > “New Campaign” > “Ad Groups”), assign all these creative variants to the same ad group. You’ll then configure the DSP’s A/B testing settings to serve them evenly at first, and then automatically shift impressions to the one that performs best based on your KPIs (like click-through rate or form fills). The “Experiment” tab in most DSPs is where you can set this up, defining the traffic split and how long the test should run.

Editorial Aside: A lot of agencies just “set and forget” their creative. This is a massive mistake in pharma. A drug’s efficacy isn’t a static concept, so why would your messaging be? You have to be testing and iterating constantly. Don’t hesitate to kill a creative that isn’t working. The result you’re aiming for is a library of high-performing ads that actually connect with HCPs, leading to better engagement and conversions, all while staying inside the regulatory lines.

Optimizing Budget Allocation and Performance Monitoring

To do media buying right for a client like Gilead Sciences, you have to be optimizing constantly to max out return on ad spend (ROAS) and hit their strict campaign goals. It’s about spending money smartly, not just spending it, and adapting to performance data as it comes in.

Step 3: Dynamic Budget Management and Bid Strategy

Forget fixed, static budgets. Modern programmatic platforms let you set up sophisticated, rule-based budget allocation that reacts to performance in real time. This dynamic method ensures your money is always flowing to the most effective channels and placements.

1. Set Up Automated Budget Rules: Inside your DSP, go to the “Campaigns” section, pick your campaign, and find “Budget & Pacing.” Most DSPs, including Magnite and Google’s DV360, have “Automated Rules” or “Budget Optimization” features. You can set up rules like: “If CPA for ‘Display – Medical Journals’ drops below $50, increase that channel’s daily budget by 10%.” Or the reverse: “If CTR for ‘Video – HCP Education Platforms’ is below 0.5% for three straight days, cut its daily budget by 15%.”
2. Implement Smart Bidding Strategies: Under “Bid Strategy” in your ad group settings, get away from manual bidding. If your goal is generating leads (like getting HCPs to sign up for trial info), choose “Target CPA” or “Maximize Conversions.” If you’re just trying to build awareness, “Target CPM” (Cost Per Thousand Impressions) or “Viewable CPM” might be better. These algorithms use a ton of data to optimize your bids automatically.
3. Adjust Frequency Capping: Blasting an HCP with the same ad over and over leads to ad fatigue and just annoys them. In your campaign’s “Settings,” find “Frequency Capping.” Set a reasonable limit, like “3 impressions per user per 7 days” for display ads and maybe “1 view per user per 14 days” for video. You need to check your “Frequency Distribution” report to make sure the caps are working and tweak them if they aren’t.
4. Monitor Bid Field and Competitive Insights: Make it a habit to check your DSP’s “Competitive Insights” or “Bid Field” reports. These show you your impression share, what others are bidding for your audience, and how intense the competition is. If your impression share suddenly tanks, it could mean a new competitor just jumped in or you need to raise your bids to stay visible.

Common Mistake: Neglecting to review your automated rules. I can’t stress this enough. While automation is a great tool, it still needs a human watching over it because a data glitch or a sudden market change can make your automated decisions go haywire. The intended result is a campaign that puts money where it works best, hits its targets, and flexes with the market to give the client the best possible shot at increasing their market share.

Reporting and Attribution Modeling for Pharmaceutical Campaigns

To prove your media spend is working for a client like Gilead Sciences, you need solid reporting and smart attribution modeling that looks beyond the simple last-click model. This is the only way to really understand the entire customer journey, especially with a sales cycle as long and complex as pharma’s.

Step 4: Complete Performance Analysis and Reporting

Being transparent and providing insights the client can actually use is mandatory. Agencies have to deliver detailed reports that draw a straight line from media dollars to business results, getting way beyond surface-level metrics.

1. Generate Custom Reports in Your Analytics Dashboard: Get into your main analytics platform, whether it’s Google Analytics 4 (GA4) or some specialized pharma analytics tool. Go to “Reports” > “Custom Reports” or “Explorations.”
2. Focus on Key Performance Indicators (KPIs): For pharma, your KPIs are different. They’ll include:
   • HCP Engagements: Clicks, how much of a video was watched, and downloads of things like clinical study PDFs.
   • Lead Generation: Form fills for sales rep follow-ups or webinar sign-ups.
   • Brand Uplift: A rise in search queries for the drug’s name or more traffic to the product pages on the website.
   • Prescription Lift (Correlative): You can’t directly attribute this, but you can correlate media exposure with anonymized prescription data from a third-party source like IQVIA, which requires a secure data clean room to execute properly.

   You need to build reports that slice these KPIs by audience segment, creative, channel, and region.

3. Implement Multi-Touch Attribution Modeling: In GA4, go to “Advertising” > “Attribution” > “Model Comparison Tool.” Don’t just use “Last Click.” Compare it to models like “Linear,” “Time Decay,” and especially “Data-Driven Attribution.” For pharma, the data-driven model is usually best because it assigns credit based on how much each touchpoint actually contributed. This gives you a much more realistic picture of how a display ad, a search ad, and a video ad all worked together to get a conversion.
4. Analyze Frequency and Recency Reports: In your DSP’s reporting section, pull the “Frequency Distribution” and “Recency” reports. Too much frequency and you get ad blindness. The right recency means your message is there when they’re most interested. Use what you find to adjust your frequency caps.
5. Provide Actionable Recommendations: A report is useless if it’s just a data dump. It needs to tell a story and have a call to action. For every point you make, give a clear recommendation. For example: “Observation: Video ad variant B is beating variant A by 25% in completion rates with oncologists in the Northeast. Recommendation: We need to put 70% of the video budget behind variant B next quarter and pull variant A to rework the creative.”

My perspective: The worst thing an agency can do is drop a report on a client with no clear next steps. The client needs to understand not just what happened, but what we should do about it. When you do this right, you get a clear picture of campaign performance that’s backed by solid data, which leads to constant improvement and proves the value of the client’s investment.

Running a smart agency strategy for accounts like Gilead Sciences means you need to know programmatic tools inside and out, understand the regulatory minefield, and be obsessed with data-driven optimization. By carefully defining audiences, aggressively testing creative, dynamically managing the budget, and using advanced attribution models, an agency can deliver real results and stay ahead in the pharma market. This whole approach ensures that every dollar of marketing spend is working as hard as it possibly can.